Epidemiological and Clinical Profile of Deaths due to COVID-19 among Hospitalized Patients in Sidama Region, Ethiopia

Table 5.

Summary of adverse events ofmechanical ventilation and survival time among COVID-19 related deaths

Variables

Mechanical ventilation (n=111)

Survival time (n=186)

Yes

No

p-value

Yes

No

p-value

Age group

 

 

 

 

 

 

18-39

18(94.7%)

1(5.3%)

0.46

25(75.8%)

8(24.2%)

0.006

40-60

44(93.6%)

3(6.4%)

 

34(50.7%)

33(49.3%)

 

≥61

49(87.5%)

7(12.5%)

 

63(73.3%)

23(26.7%)

 

Sex

 

 

 

 

 

 

Male

78(89.7%)

9(10.3%)

0.509f

86(63.7%)

49(36.3%)

0.489

Female

33(94.3%)

2(5.7%)

 

36(70.6%)

15(29.4%)

 

Comorbidity

 

 

 

 

 

 

Yes

74(87.1%)

11(22.9%)

0.033f

77(64.2%)

43(35.8%)

0.631

No

37(100%)

0

 

45(68.2%)

21(31.8%)

 

Number of comorbidity

 

 

 

 

 

 

One

50(92.6%)

4(7.4%)

0.089f

50(64.9%)

27(35.1%)

0.814

Two or more

24(77.4%)

7(22.6%)

 

27(62.8%)

16(37.8%)

 

Type of comorbidity

 

 

 

 

 

 

Diabetes

40(85.1%)

7(14.9%)

0.747f

39(65%)

21(35%)

0.849

Hypertension

29(85.3%)

5(14.7%)

0.748f

33(70.2%)

14(29.8%)

0.268

HIV/AIDS

2(66.7%)

1(33.3%)

0.344f

4(57.1%)

3(42.9%)

0.7

Cancer

1

0

1.00

3(60%)

2(40%)

1.00

Asthma

6(85.7%)

1(14.3%)

1.00

4(50%)

4(50%)

0.455

Renal disease

7(77.8%)

2(22.2%)

0.329f

11(78.6%)

3(21.4%)

0.232

Stroke

2(66.7%)

1(33.3%)

0.344

4

0

0.295

Cardiac disease

7(77.8%)

2(22.2%)

0.329f

7(53.8%)

6(46.2%)

0.541

f; fisher exact test

f; fisher exact test